Reimbursement

Top news of the week from Specialty Pharmacy Times.

Specialty pharmacies that offer effective medication therapy management and support are best suited to serve as arbiters of the next generation of value-based contracts.

Specialty pharmacies will need to carefully consider the effect of the final rule regarding Anti-Kickback Statute safe harbors and Civil Monetary Penalty Law exceptions on their existing patient benefit programs.

With the growth of fitness apps, electronic health records, and telemedicine, mobile health is poised to enter the specialty pharmacy space.

Eric Peacock, CEO of MyHealthTeams, discusses how the role patients take in their own care is rapidly evolving in the technological era.

Daniel P. Kus, BS Pharm, RPh, discusses how specialty pharmacies can help patients manage out-of-pocket drug spending.

Top news of the week on Specialty Pharmacy Times.

Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.

Top news of the week on Specialty Pharmacy Times.

Mark Tesell, PharmD, BCPS, discusses trends that could impact specialty pharmacy well into the future.

Pharmacists most frequently become the formal and informal leaders for the specialty pharmacies they work in.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses effective measures for maintaining adherence to specialty drug regimens.

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses the challenges patients face when starting a specialty medication regimen.

Advances in the support of patients with HIV include remarkable new pharmaceutical therapies, collaborative care, outstanding patient support, and medication management.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.

Last week, the House of Representatives passed an updated version of the 21st Century Cures Act, which could have a significant impact on specialty pharmacy.

Proper succession planning for your pharmacist-in-charge is a must for continuity of business.

Top news of the week on Specialty Pharmacy Times.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses the implications of the Medicare Home Infusion Site of Care Act for specialty pharmacy stakeholders.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty stakeholders will need to alter current patient management programs as new drugs transform the treatment of diseases into more manageable conditions.

John Campo, vice president of Specialty Pharmacy Trade Relations and Contracting at Managed Health Care Associates, discusses optimal use of data analytics in specialty pharmacy.

Top articles of the week on Specialty Pharmacy Times.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best support patients on a specialty drug therapy.

Premiums in employer plans are growing more slowly on average, as are individual income levels.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how the growing population of older Americans could impact the specialty pharmacy landscape.

Top articles of the week on Specialty Pharmacy Times.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses lessons the specialty industry learned from the impact of high cost drug launches for hepatitis C and high cholesterol.

Developing industry connections is crucial for aspiring pharmacists.